Search

everythinglearnresearchcommunity

for

Search:↓

Cancer survivors need better skin care to improve their quality of life.

Dermoscopy helped correctly diagnose a skin condition that was previously misidentified as a different hair loss disease.

Using minoxidil on balding scalps can stimulate hair regrowth and increase blood flow. It's an effective treatment for early hair loss.

The document concludes that a thorough history, physical exam, and specific tests are crucial for diagnosing and managing hair loss effectively.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Scalp cooling is cost-effective for reducing hair loss from chemotherapy and should be covered by insurance.

Blacks and Hispanics have higher chances of alopecia areata than Whites.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Carbamazepine can cause hair loss, which may reverse when the medication is stopped.

Baricitinib may effectively treat oral lichen planus.

Telogen effluvium patients have a worse quality of life, but similar self-esteem compared to others.

Losartan may help treat Postural Orthostatic Tachycardia Syndrome (POTS) symptoms.

Social media videos made by dermatologists significantly improved patient knowledge about hair loss.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Common skin conditions can greatly affect a person's mental health and social life.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Guidelines for full-body skin exams, including hidden areas, are needed to guide doctors and inform patients.

Regenerative medicine shows promise for treating skin disorders like hair loss and vitiligo.

Hormonal therapies effectively treat acne and improve quality of life.

An HIV patient with IRIS had rare syphilis symptoms affecting skin, eyes, and nerves.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

Alopecia in lupus patients is often underdiagnosed and rarely biopsied.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

Dermatologists perform most outpatient cosmetic procedures in the U.S., especially on white women aged 40 to 59.

Dermatologists performed the most outpatient cosmetic procedures in the U.S. from 1995 to 2003, especially on white women aged 40 to 59.

Many people with skin conditions don't seek professional help, often due to self-management beliefs.

Dermatologists should understand cultural practices and communicate empathetically to effectively treat skin conditions in children and teens of color.

Direct-to-consumer teledermatology is growing fast but raises concerns about quality of care and doctor-patient relationships.

Telemedicine is effective for managing alopecia areata follow-ups.